Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Afr J Tradit Complement Altern Med ; 14(2): 234-240, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28573240

RESUMO

BACKGROUND: The goal of this study was identification signaling molecules mediated the formation of AGEs in brain of rats injected with CdCl2 and the role of camel whey proteins and Brassicaceae extract on formation of AGEs in brain. METHODS: Ninety male rats were randomly grouped into five groups; Normal control (GpI) and the other rats (groups II-V) were received a single dose of cadmium chloride i.p (5 µg/kg/b.w) for induction of neurodegeneration. Rats in groups III-V were treated daily with whey protein (1g/kg b.w) or Brassicaceae extract (1mg/kg b.w) or combined respectively for 12 weeks. RESULTS: It was found that whey protein combined with Brassicaceae extract prevented the formation of AGEs and enhance the antioxidant activity compared with untreated group (p <0.001). Serum tumor necrosis factor (TNF-α) and interleukine (IL-6) levels were significantly decreased (p<0.01) in rats treated with whey protein and Brassicaceae extract formation compared with untreated. The combined treatment showed a better impact than individual ones (p<0.001). The level of cAMP but not cGMP were lowered in combined treatment than individual (p<0.01). CONCLUSION: It can be postulated that Whey protein + Brassicaceae extract formation could have potential benefits in the prevention of the onset and progression of neuropathy in patients.


Assuntos
Antioxidantes/farmacologia , Encéfalo/efeitos dos fármacos , Brassicaceae , Produtos Finais de Glicação Avançada/metabolismo , Doenças Neurodegenerativas/metabolismo , Extratos Vegetais/farmacologia , Proteínas do Soro do Leite/farmacologia , Animais , Antioxidantes/metabolismo , Antioxidantes/uso terapêutico , Encéfalo/metabolismo , Cloreto de Cádmio , Camelus , AMP Cíclico/metabolismo , Quimioterapia Combinada , Produtos Finais de Glicação Avançada/sangue , Interleucina-6/metabolismo , Masculino , Doenças Neurodegenerativas/sangue , Doenças Neurodegenerativas/tratamento farmacológico , Extratos Vegetais/uso terapêutico , Distribuição Aleatória , Ratos , Transdução de Sinais , Fator de Necrose Tumoral alfa/sangue , Proteínas do Soro do Leite/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA